<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>Reclassification Recommendations for Drug in ‘Magic Mushrooms’</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2018/10/01/reclassification-recommendations-for-drug-in-magic-mushrooms.aspx</link><description>If researchers at Johns Hopkins Medicine get their way, psilocybin, a component of something known as &amp;ldquo;magic mushrooms,&amp;rdquo; may be declassified from a Schedule I drug to a Schedule IV. A Schedule 1 drug is categorized as such if federal regulators</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>